Washington: (HRNW) US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is “highly effective” in adolescents aged 12-17 and the company would seek regulators’ approval in June.
“We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents,” CEO Stephane Bancel said in a statement.
“We will submit these results to the US FDA and regulators globally in early June and request authorization.”
If greenlit, as expected, it would be the second Covid vaccine authorized for use in US adolescents after Pfizer’s, which began rolling out this month for 12-to-15-year-olds.
Be the first to comment on "Moderna Says Covid Vaccine “Highly Effective” In Adolescents"